Profile
Ian Stuart Muir served as Managing Director & Director at Pharmaron Manufacturing Services (UK) Ltd.
He was also a Director at Aesica Formulation Development Ltd.
from 2014 to 2017.
Prior to that, he held Principal positions at Wyeth LLC, Cardinal Health, Inc., Faulding, Inc., Catalent Pharma Solutions, Inc., and Bristol-Myers Squibb Holdings Pharma LLC.
Muir earned a doctorate degree from The University of Nottingham and an undergraduate degree from De Montfort University.
Former positions of Ian Stuart Muir
Companies | Position | End |
---|---|---|
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Director/Board Member | 2017-05-17 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
Pharmaron Manufacturing Services (UK) Ltd.
Pharmaron Manufacturing Services (UK) Ltd. Pharmaceuticals: MajorHealth Technology Pharmaron Manufacturing Services (UK) Ltd. operates as pharmaceutical contract development and manufacturing company. It offers process research and development, analytical, clinical manufacturing and trial supply, and regulatory and support chain services. The company was founded in 2004 and is headquartered in Hemel Hempstead, the United Kingdom. | Chief Executive Officer | - |
Faulding, Inc. | Corporate Officer/Principal | - |
Training of Ian Stuart Muir
The University of Nottingham | Doctorate Degree |
De Montfort University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
Private companies | 6 |
---|---|
Bristol-Myers Squibb Holdings Pharma LLC
Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Pharma Ltd. engages in the pharmaceutical company. The company is headquartered in San Juan, Puerto Rico. | Health Technology |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Faulding, Inc. | Health Technology |
Pharmaron Manufacturing Services (UK) Ltd.
Pharmaron Manufacturing Services (UK) Ltd. Pharmaceuticals: MajorHealth Technology Pharmaron Manufacturing Services (UK) Ltd. operates as pharmaceutical contract development and manufacturing company. It offers process research and development, analytical, clinical manufacturing and trial supply, and regulatory and support chain services. The company was founded in 2004 and is headquartered in Hemel Hempstead, the United Kingdom. | Health Technology |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Ian Stuart Muir